Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
PlateletGenex Functional Defect Panel (31 genes) (2 Day STAT TAT) Machaon Diagnostics United States | 26 | 31 |
|
Centogene AG - the Rare Disease Company Germany | 110 | 112 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 249 | 155 |
|
Platelet bleeding disorders Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 31 | 34 |
|
Platelet bleeding disorders Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 31 | 34 |
|
Platelet bleeding disorders NGS panel HNL Genomics Connective Tissue Gene Tests United States | 31 | 34 |
|
PreventionGenetics, part of Exact Sciences United States | 78 | 79 |
|
Haematological diseases panel _v.2.0 CGC Genetics Unilabs Portugal | 1 | 344 |
|
CGC Genetics Unilabs Portugal | 1 | 121 |
|
Mendelics Brazil | 1 | 51 |
|
Bleeding disorder / coagulopathy panel. NGS panel of 62 genes. Genologica Medica Spain | 96 | 62 |
|
Comprehensive Bleeding Disorder Panel Versiti Diagnostic Laboratories Versiti, Inc United States | 80 | 66 |
|
von Willebrand Disease Genetic Analysis MNG Laboratories (Medical Neurogenetics, LLC.) United States | 1 | 2 |
|
Platelet Function Genetic Analysis MNG Laboratories (Medical Neurogenetics, LLC.) United States | 3 | 31 |
|
NewbornDx Advanced Sequencing Evaluation Athena Diagnostics United States | 1 | 1722 |
|
Fulgent Genetics United States | 74 | 44 |
|
Comprehensive Thrombosis, Platelet Disorder, and Coagulation Deficiency NGS Panel Fulgent Genetics United States | 146 | 82 |
|
Comprehensive Hematology Panel Blueprint Genetics Finland | 4 | 239 |
|
Bleeding Disorder/Coagulopathy Panel Blueprint Genetics Finland | 7 | 62 |
|
Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University United States | 12 | 55 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.